April 16, 2026

 

United States Securities and Exchange Commission

Division of Corporation Finance

Attn: Tyler Howes

100 F Street, N.E.

Washington, DC 20549

 

  Re: Propanc Biopharma, Inc.
    Registration Statement on Form S-1
    Filed April 10, 2026
    File No. 333-295002

 

Ladies and Gentlemen:

 

The undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective on April 20, 2026 at 12:00 p.m. Eastern Daylight Time, or as soon thereafter as practicable.

 

The Registrant authorizes Chase Chandler of Brunson Chandler & Jones, PLLC, outside counsel to the Registrant, to verbally alter the requested date and time of effectiveness of the Registration Statement with the Commission. Please call Mr. Chandler at (801) 303-5772 with any questions.

 

Very truly yours,

 

Propanc Biopharma, Inc.  
   
/s/ James Nathanilesz  
James Nathanilesz  
Chief Executive Officer